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Dear Editors, 
  We would like to submit for your consideration our paper entitled: 
"Systematic bioinformatics and experimental validation of yeast complexes reduces 
the rate of attrition during structural investigations" for consideration as a "Ways and 
Means" article.  This paper consolidates our experience on the use of large data sets, 
the yeast proteome - interactome, as the basis to for structural studies of protein 
complexes.  Our results were obtained as part of a large European collaborative 
project, 3D-repertoire, which has brought together various laboratories with 
experience in systems biology, bioinformatics, structural biology and molecular 
biology, in an effort to provide new insight to the yeast proteome. A significant part of 
that effort was to provide new structural data of protein complexes, as the basis to 
promote our understanding of specific protein interactions in eukaryotic cells. 
In this paper we exemplify a procedure combining bioinformatics tools for complex 
selection, in vivo validation and heterologous recombinant expression technologies, to 
deliver structural results in a medium-throughout manner. In addition, we showcase a 
test of twenty yeast complexes that were treated in this manner, and discuss in more 
detail one such complex that went all the way from identification to structural 
characterization. 
To our knowledge this is the first time than an objective study has been done to 
evaluate the importance of bioinformatics analysis on pull down results to select the 
best possible targets for structural characterization. We believe this report is of broad 
interest to the molecular and structural biology communities, and that Structure is the 
ideal vehicle to bring our results to the attention of the broad readership that we wish 
to address.  
The authors declare that they have no conflict of financial interest with the work 
presented herein. 
Yours sincerely, 
Anastassis Perrakis 
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Abstract 
For high-throughput structural studies of protein complexes of composition 
inferred from proteomics data, it is crucial that candidate complexes are selected 
accurately. Herein, we exemplify a procedure that combines a bioinformatics tool for 
complex selection with in vivo validation, to deliver structural results in a medium-
throughout manner. We have selected a set of twenty yeast complexes, which were 
predicted to be feasible by either an automated bioinformatics algorithm, by manual 
inspection of primary data, or by literature searches. These complexes were validated 
with two straightforward and efficient biochemical assays, and heterologous 
expression technologies of complex components were then used to produce the 
complexes to assess their feasibility experimentally. Approximately one half of the 
selected complexes were useful for structural studies, and we detail one particular 
success story. Our results underscore the importance of accurate target selection and 
validation in avoiding transient, unstable, or simply non-existent complexes from the 
outset. 
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Introduction 
Numerous large-scale proteomics initiatives in the model organism 
Saccharomyces cerevisiae have been reported over the last few years, and have 
provided evidence for thousands of new protein interactions and supplied a wealth of 
information about the composition of macromolecular complexes (Gavin et al., 2006; 
Ho et al., 2002; Ito et al., 2001; Krogan et al., 2006; Tarassov et al., 2008; Uetz et al., 
2000). Nevertheless, the characteristics of protein interaction networks in vivo have 
not yet been rigorously untangled for any organism, let alone the faithful budding 
yeast. Now that such protein interaction datasets are in the public domain, a gauntlet 
has been thrown down to the scientific community to provide tools for assimilating 
these data with a view to developing algorithms and experimental methodologies for 
predicting the composition of complexes with high accuracy, thereby facilitating their 
functional and structural characterization.   
However, for many predicted complexes identified in high-throughput affinity 
purification experiments, their subunit composition is not established with sufficient 
reliability to proceed to structure determination. Improvements in the confidence that 
can be placed in protein interaction models are therefore clearly needed, with the 
specific aim of identifying complexes with well-defined stoichiometry, and which are 
amenable to structural studies. Raising the confidence with which complex 
composition could be predicted would benefit enormously the field of structural 
biology. Ideally, it would be possible to identify stable complexes (for example 
ribosomes, RNA polymerases, the exosome, or the 20S proteosome) and discriminate 
them from more dynamic assemblies that contain transient interactors (for example 
spliceosomes or the 26S proteosome). It would therefore be beneficial to classify and 
characterize the various entities which form the central frameworks of protein-protein 
interaction networks (Gavin et al., 2006; Higurashi et al., 2008; Krogan et al., 2006). 
Foremost among the problems encountered in complex characterization are 
those related to the primary data being of limited quality. For example, the 
heterogeneity or the extremely dilute nature of samples from proteomic experiments 
results in complex subunits being overlooked. Additionally, in some studies, the 
characterization of complex composition has been hindered by the contamination of 
bona fide complexes by so-called „background‟ or „sticky‟ polypeptides that interact 
 5 
with other proteins in a promiscuous fashion (Shevchenko et al., 2002). One challenge 
is therefore to devise a computational strategy to filter through the results of many 
thousands of biochemical purifications which have been performed to date, and 
identify the complexes that will yield the optimal results during expression and 
purification studies (Bravo and Aloy, 2006).  
The first structural genomics consortia focused on the determination of X-ray 
and NMR structures at the level of the single protein (Alzari et al., 2006; Graslund et 
al., 2008; Marsden and Orengo, 2008). More recently, the Structural Genomics 
Consortium (SGC)(Edwards et al., 2002), the 3D Repertoire 
(http://www.3drepertoire.org/) and SPINE 2 - Complexes (http://www.spine2.eu/) 
consortia have opted to study macromolecular complexes from a medium-throughput 
perspective. The expression and purification of protein complexes adds an extra level 
of complexity, since globular protein interfaces are often partly hydrophobic, and 
single partners may be insoluble. In many cases, only in the context of an assembled 
complex do hydrophobic interfaces become buried and the participating polypeptides 
can be produced as soluble entities (Dyson and Wright, 2005; Smialowski et al., 
2007). 
Since the inception of the European Commission-funded consortium “3D 
repertoire” in 2004, collaborating scientists have been addressing the problems 
associated with identifying complexes de novo for structural studies. Within the first 
step, which consisted of highly selective filtering of existing datasets for evidence of 
the existence of complexes in a process we term „complex triage‟, three methods were 
employed. Firstly, a bioinformatics-based selection procedure, optimized using a 
training set composed of complexes of known three-dimensional (3D) structure, was 
used to screen for stable, well-folded complexes. Secondly, we examined the results 
from high throughput affinity purification experiments manually, focusing on the 
visual inspection of gels to identify complexes of which the components existed in 
stoichiometric quantities. Finally, a set of seven complexes was chosen on the basis of 
the scientific literature. 
A compilation of these complexes, named the 'list of 20', were then validated 
by new affinity purifications of the natural complexes and their subunit compositions 
were confirmed using mass spectrometry. In addition, the solution sizes of these 
complexes were assessed by size exclusion chromatography. The subset of proteins 
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that were shown to indeed participate in macromolecular assemblies as predicted and 
that was also believed to be tractable for structural studies was then cloned and 
expressed in E. coli. Using various techniques, we aimed to obtain purified material 
suitable for structural analysis. We show the overall success in each of the steps of 
this procedure and present a detailed account of one example complex. The results 
from this test set of complexes under investigation have allowed us to evaluate the 
effectiveness of each of the techniques used and devise an optimal route for the 
production of protein complexes in structural biology pipelines. 
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Results 
Identification of complexes for structural studies 
Complex triage by bioinformatics  
A system has been previously described for the ranking of the 491 complexes 
and the 5,488 isoforms that we had previously described from over 2,000 successful 
tandem affinity purifications (Gavin et al., 2006). This was based on the notion that 
target complexes likely amenable to structural studies should be small, compact and 
homogeneous. We considered biophysical, biochemical and large-scale proteomics 
data in the form of partial scoring functions that were normalized and combined into a 
final feasibility score for each complex (c.f. Methods, Supplemental Methods, and as 
described previously (Pache and Aloy, 2008); referred to hereafter as the Complex 
Feasibility (CF) algorithm). In this way, the public domain data were filtered to 
generate a much-reduced subset of credible complexes. To generate a list of a total of 
seven complexes by the CF tool, we combined four of the top ranking choices with 
three mid-ranking complexes (Table 1, Table S3). 
Complex triage by manual visualization of gels 
In the original genome-wide approach (Gavin et al., 2006), tandem affinity 
purified (TAP) assemblies were separated by denaturing gel electrophoresis and 
stained. The gels were then cut into 1 mm slices, digested with trypsin and analyzed 
by MALDI–TOF mass spectrometry (MS). However, this procedure did not take into 
account the relative quantities of proteins present in the TAP eluate. Complexes with 
apparent sub-stoichiometric components are more likely to depend on labile transient 
interactions and less suitable for structural studies than stable stoichiometric 
assemblies. We thus decided to visually inspect the original gels (Gavin et al., 2006) 
for bands indicative of stoichiometric complexes. The resulting assemblies were 
narrowed down to dimers, trimers and tetramers. Thorough inspection of about 4,000 
purification experiments, we identified 64 promising complexes (Table S4; dimeric 
complexes, Table S5; trimeric complexes, Table S6; tetrameric complexes). Not all of 
the 64 chosen complexes were present in the computational selection, simply because 
some of these were not identified as being complexes in the original automated 
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annotation (Gavin et al., 2006). Notably, the best six complexes that were chosen 
independently by gel inspection were all in the top-50 of the CF algorithm, and two of 
them were in the top-10. Six complexes were finally selected by manual gel 
inspection (Table 1). 
The list of ‘20 complexes’ 
In Table 1, we show the 20 complexes selected, with the corresponding 
bioinformatics and gel scores, and when possible appropriate references to the 
literature. Although the manual gel inspection and the bioinformatics efforts were 
independent, all previously identified complexes selected by manual screening had a 
high ranking using the CF algorithm. In contrast, not all of the complexes chosen by 
the algorithm could be associated with clear and conclusive gels. Notably, a top-
ranked choice was associated with a gel of mediocre quality. Nonetheless, such types 
of selections resulted in a potentially interesting collection of complexes that would 
hopefully be amenable to structural studies. The selection was complemented by the 
choice of an additional seven complexes suggested by partners of 3D repertoire, based 
on specific biological interests and literature know-how, reaching the final number of 
20 complexes included in this study. Interestingly, only one of the latter choices was 
in the top-10 bioinformatics list, and an additional two were in the top-50; the 
remaining four scored poorly by the CF algorithm. 
Validation of complex composition 
The twenty selected complexes were validated in a two-step TAP purification 
on IgG and calmodulin columns. Mass spectrometry analyses using an ESI-TRAP 
approach were performed using both the eluate solutions and the excised gel bands as 
samples. In addition, molecular weights of complexes were estimated by size 
exclusion chromatography of total extracts, followed by dot-blot detection of TAP-
tagged proteins in eluate fractions. Finally, the molecular weights of tagged subunits 
and the efficiency of binding to IgG resin were verified by Western blot analyses (see 
Figure 1 for a schematic representation of the procedure). The conclusions regarding 
individual complexes are presented in Table 1 and Figure S1.  
Only two of the complexes completely failed this validation stage, one for 
technical reasons and one could not be identified at all. Interestingly, both complexes 
originated from the literature additions to the list and they both scored poorly in the 
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bioinformatics assessment. This category, where literature knowledge was used to 
select complexes, gave a lower validation rate than the other strategies. Apart from 
the one complex for which no technically valid results were obtained, one failed, 
while two others showed too weak native expression to be conclusive. Another 
complex was highly heterogeneous and one included a very promiscuous protein as a 
partner and was thus inconclusive. Notably, one complex selected from the literature 
and validated here to be „excellent‟, was ranked in the top-10 (20th percentile) of the 
bioinformatics list. The low validation rates of complexes selected from the literature, 
and their low bio-computing ranks stem from their specific characteristics (low 
abundance, specific interaction involving abundant partners flagged as promiscuous) 
and underline the limitation of current strategies to identify bona fide complexes. The 
gel-selected complexes and the bioinformatics complexes fared well in the validation, 
with four out of six and three out of seven, respectively, being scored as 'excellent'. 
From the validated complexes, eleven were chosen for heterologous expression 
studies and production in quantities suitable for structural studies. Analysis of the 
twelfth complex, Dom34:Hbs1 is described elsewhere, so was not repeated (Graille et 
al., 2008), but is included in Table 1. 
Recombinant production of complexes for structural studies 
For these eleven complexes, a mixture of expression strategies was employed 
for their evaluation: expression of the full-length individual subunits, in vitro complex 
reconstitution from subunits, and co-expression. A total of twenty-two proteins have 
been used in expression trials as single full-length proteins in E. coli, either from 
synthetic, codon-optimized genes (16 proteins, Figure 2, panel A) or from natural 
yeast genes (Figures S2, S3, S4, S5 and S6). Only three of these failed to produce 
soluble protein in appreciable amounts (Atg29, Psy4 and Ste11). We proceeded to 
reconstitute three complexes (Vps27:Hse1, Ptc2:Paa1 and Gcd10:Gcd14) from 
individually purified partners and succeeded in purifying them in soluble form and 
defined subunit composition. In parallel, we also attempted co-expression of nine 
complexes, and we were able to produce seven out of nine complexes by such co-
expression methods, (Figure 2, panel B).  
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A case study of an example complex, from selection to validation 
To illustrate the course of an experiment from target selection to validation, 
we present one particular exemplary complex. The Gcd10:Gcd14 complex was 
originally identified a few years ago and purified as a dimeric tRNA(1-
methyladenosine) methyltransferase (Anderson et al., 1998; Anderson et al., 2000; 
Ozanick et al., 2007). Gavin et al. (Gavin et al., 2006) observed again this dimeric 
complex, which was annotated as Complex 376 in the Krogan et al. enumeration 
(Krogan et al., 2006). TAP purified Gcd10:Gcd14 has also been shown to be 
relatively homogeneous and therefore pure by electron microscopy. We selected this 
complex by gel analysis but it also ranked with a score of 12 by the CF algorithm. 
Firstly, we re-validated the complex by repeating the TAP purification using 
tagged Gcd14 and the only partner that was isolated was Gcd10, with no other bands 
either apparent or identified by mass spectrometry Figure 3, panels A and B). Gel 
filtration analysis of the TAP-tag purified complex was consistent with a molecular 
weight of approximately 350 kDa, suggesting the formation of higher-order multimers 
since the expected mass of the Gcd10:Gcd14 complex with a 1:1 stoichiometry is 
98.3 kDa. 
The complex was reconstituted from the Ni
2+-
-NTA purified individual 
components and subjected to gel filtration chromatography. The resulting complex 
had an approximate molecular weight of around 350 kDa, in agreement with the 
analysis of the 'native' TAP-tagged complex (Figure 3, panel B). The purified 
complex was then used in a negative stain electron microscopy experiment. The 
sample was homogeneous and could be used for data collection (Figure 3, panel C). 
Image reconstructions without any imposed symmetry showed a tetrameric core with 
extensions at opposite surfaces, giving the entire complex two-fold, as well as quasi 
four-fold symmetry. Therefore, C2-symmetry was imposed for further refinement. 
The final reconstruction is shown in Figure 3, panel E. Projections of this 
reconstruction agree with class averages were determined by multivariate statistical 
analysis (Figure 3, panel D). 
 
 11 
Discussion 
In this work, we set out to identify an optimal strategy for the analysis of 
Saccharomyces cerevisiae complexes by combining contemporary structural biology 
tools with the numerous proteome-level biochemical interaction datasets. Our central 
tenet was that we believed such data to be essentially reliable, the use of improved 
bioinformatics tools, manual analysis of gels or bibliographic curation of previous 
data should allow the identification of complexes best suited to structural analysis.  
A question that we sought to answer related to whether bioinformatics, and 
specifically the CF algorithm, could provide trustworthy guidance when selecting 
targets. Ideally, the algorithm should eliminate the need for manual inspection of data. 
Therefore, we first generated a target list, partly using automated tools and partly 
manually. The next step was to ascertain which of the selected complexes do indeed 
exist in a stable and stoichiometric form. Our experimental results show that the 
bioinformatics algorithm could select targets with a validation success rate that was 
very high, and comparable to visual inspection of gels. 
In the final CF algorithm, the most important parameters were the yeast two-
hybrid ratio and the socio-affinity index (Table S2). The usefulness of the former 
parameter has been obvious for some time, since yeast two-hybrid screening has been 
a mainstay of research into protein-protein interactions. However, the important role 
of the socio-affinity index in this experiment was encouraging (Gavin et al., 2006), 
and we believe that it is a valuable and powerful metric for the identification of 
protein complexes based on protein interaction datasets. Conversely, the least useful 
parameters were the „average number of problematic residues‟ and the „co-
localization ratio‟; it appears that these parameters are not as useful as had been 
previously thought, at least in the context of this work (Pache and Aloy, 2008).  
We note that some complexes identified by bibliographic analyses, which 
could not be validated and for which low scores were obtained with the CF algorithm, 
performed well using recombinant expression. These facts underline the limitation of 
complex analyses of low abundance complexes and/or complexes involving very 
abundant subunits for which it is difficult to exclude the existence of promiscuous 
interactions. It is possible that our complex triage procedures have been successful at 
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least in part, due to the clarity of primary data for which the subunits are 
stoichiometrically equivalent and well expressed.  
 
The success rate of obtaining soluble subunits by heterlogous recombinant 
expression, for the full-length proteins was high (only 3 of 22 proteins tested could 
not be produced in a soluble form; 86% success rate). Similarly, we were able to 
obtain soluble complexes corresponding to most of our validated targets using either 
complex reassembly or co-expression via either co-transformation of plasmids or 
single plasmids that contain operons encoding all of the proteins of interest (c.f. Table 
1, and Supplemental Material; 9 of 11 complexes could be formed; 82% success rate). 
We believe that this achievement is principally due to the efficient selection criteria 
that we had established. It has been reported that only about 20% of full-length 
eukaryotic proteins are soluble when produced in a heterologous expression system 
(Graslund et al., 2008), but the performance of our approach is considerably superior. 
This is likely to be because only natively soluble proteins and complexes that are 
expressed at suitably high levels are detected by mass spectrometry after TAP 
purification, thereby biasing complex identification data towards soluble proteins. 
Based on the four-year experience of a consortium of numerous structural 
biology groups involved in 3D repertoire, we suggest an optimal experimental 
strategy for the high-throughput study of protein complexes. We conclude that despite 
the absence of a „silver bullet‟, much can be achieved first by triaging the targets by 
an efficient computational procedure, followed by simple expression and 
reconstitution in the first instance. For this, a LIC-based strategy to clone optimized 
synthetic genes in a parallel manner resulted in notable success, with 14 of 16 
subunits expressed in soluble form. During complex reconstitution, we had greater 
success when employing co-sonication of E. coli in which each subunit had been 
expressed separately, compared to reconstitution using pure proteins and has become 
our method of choice to obtain soluble complexes (c.f. Supplemental Experimental 
Procedures; „Complex formation trials‟).  
We also found that producing plasmids that encode the necessary subunits as 
synthetic DNA, with Shine-Dalgarno sequences upstream of the successive ORFs to 
be a very practical and rapid method of co-expressing complexes (c.f. Supplemental 
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Experimental Procedures; „Cloning strategy used for poly-cistronic expression‟). Our 
studies into the use of polycistronic vectors, particularly those constructed from 
synthetic genes (e.g. Gcd10:Gcd14 and Ssl2:Yor352 complexes, Figure S8) indicate 
that this is a strategy that this is a useful addition to pipelines, both because of the 
ease of production of plasmid constructs, and the increase in yield presented by 
codon-optimized genes. 
In summary, we conclude that when initiating projects involving high-
throughput study of protein complexes, proper triaging and validation is obligatory. 
Once this had been performed, it was relatively straightforward to test the association 
of the recombinant proteins experimentally. As we illustrate with the Gcd10:Gcd14 
complex, we were able to obtain structural information during the relatively short 
time scale of this project. In this work, we have leveraged complementary strategies 
to the end of complex production for structural analysis, but we envisage the 
incorporation of further techniques in subsequent experiments. For example, high 
throughput small angle X-ray scattering studies of single proteins could be applied 
similarly to complexes (Hura et al., 2009), and it will be increasingly important to 
identify complex and sub-complex composition of samples purified directly from 
cells using native mass spectrometry (Hernandez et al., 2006). Accurate subunit 
prediction and validation methods will be beneficial to future high-throughput 
approaches geared towards „high-hanging fruit‟ and increase the probability that such 
efforts will yield illuminating insights into macromolecular machines at work. 
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Figure Legends 
Figure 1: Strategy for the validation of selected complexes 
A schema showing the overall pathway for the validation of complex composition and 
estimation of molecular weight of each complex is presented. The complexes were 
expressed in yeast using a C-terminal TAP-tag of the bait protein. Following cell-
breakage, complexes were either subjected to TAP purification to assess the subunit 
composition, or to gel filtration in order to estimate the molecular weight, and thereby 
their stoichiometry. See Figure S1 for actual results of the validation experiments. 
Figure 2: Expression and purification of yeast full-length proteins 
Panel A: SDS-PAGE analysis of full-length yeast constructs produced using codon-
optimized synthetic genes, Ni
2+
-NTA-purified and visualised using Coomassie. Full-
length proteins were expressed and purified as above and eluted material was 
analysed by SDS-PAGE. The samples are relatively pure after only one step of 
purification, although degradation products are sometimes present. Molecular weight 
markers and their sizes are indicated on both sides of the gel. Successful constructs 
are: Atg17 (48.7 kDa), Dug2 (98.1 kDa), Dug3 (40.2 kDa), Gcd10 (54.4 kDa), Gcd14 
(43.9 kDa), Met12 (73.9 kDa), Met13 (68.6 kDa), Psy2 (98.1 kDa), Rbg2 (41 kDa), 
Gir2 (31 kDa), Ssl2 (95.3 kDa), Yor352w (39.3 kDa), Vps27 (71.9 kDa), Hse1 (51.1 
kDa), while the unsuccessful constructs are: Atg20 (72.5 kDa) and Psy4 (50.7 kDa). 
Panel B: The nine complexes successfully produced in a recombinant form. Ni
2+
-
NTA-purified samples of the results of complex formation trials were subjected to 
SDS-PAGE analysis and visualised using Coomassie. Co-expressed or reconstituted 
forms of the Gcd10:Gcd14 (54.4 and 43.9 kDa, respectively), Paa1:Ptc2 (21.9 and 
50.3 kDa), Met12:Met13 (73.9 and 68.6 kDa), Dug2:Dug3 (98 and 40.2 kDa), 
Ssl2:Yor352w (95.2 and 40.2 kDa), Hbs1:Dom34 (68.7 and 44.1 kDa), Vps27:Hse1 
(71.9 and 51.1 kDa), Gir2:Rbg2 (31 and 41 kDa), Dug2:Dug3 (98.1 and 40.2 kDa), 
Rps28B:Edc3 (7.6 and 61.3 kDa) complexes. Bands corresponding to the proteins of 
interest are arrowed. See also Figure S2 for detailed results of expression and 
reconstitution of complexes. 
Figure 3: Validation and scale-up of an exemplary complex; Gcd10:Gcd14 
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A) Both Gcd10 and Gcd14 were clearly visible after purification using the TAP 
protocol, with little evidence of contaminating proteins, validating this complex. B) In 
order to estimate the size of the complexes, yeast extracts were separated with the use 
of size exclusion chromatography on a Superdex 200 column in low (150 mM; 
marked as „LO‟) and high (500 mM; „HI‟) concentration of NaCl. 30 fractions from 
this chromatography step were collected and spotted on a nitrocellulose membrane. 
To detect fractions containing the TAP tagged protein, western blotting using PAP 
antibodies was performed. See the legend to Figure S1 for further details to panels A 
and B. C) Micrograph of the Gcd10:Gcd14 complex which had been purified as in 
Figure 2, panel B, and fixed with glutaraldehyde, according to the GraFix protocols 
(Kästner et al., 2008) and stained with uranyl-acetate in a sandwich between two 
layers of carbon. The length of the scale bar equals 50 nm. D) Class averages of the 
data (top row) determined by multi-statistical analysis agree with projections of the 
3D-map (central row). Surface presentations (bottom row) of the 3D-map are shown 
in the same directions as the projections above. The length of the scale bar equals 5 
nm. E) Image reconstruction of the Gcd10/Gcd14 complex. C2 symmetry was 
imposed during the final rounds of refinement. The complex is shown along the 
symmetry axis (left) and perpendicular to the symmetry axis (right). The length of the 
scale bar equals 5 nm.  
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Tables 
Table 1: Summary of target selection, validation and complex reconstitution results. 
Complexes selected by bioinformatics, gel and literature analyses respectively, are listed. The 
complexes were assessed according to their purity after TAP purification (column labeled 
“Gel quality”). The ranks according to the CF algorithm of each of the complexes (“Rank”), 
as well as the results of validation by tandem affinity purification (c.f. Figure S1; “TAP 
Validation” and Figure S2 for the results of complex production and Table S7) are shown. 
Results of expression, co-expression and reconstitution studies are as follows: +; successful, -
; unsuccessful, ND; not determined, NA; not applicable. *; Few of the complexes consist of 3 
or more subunits. 
¥
The Gcd10:Gcd14 complex was not reconstituted from purified proteins, 
but instead cells in which the proteins had been expressed separately were combined prior to 
sonication. For clarity, results that were deemed to be „positive‟ (having a „good‟ gel quality, 
high ranking in the bioinformatics triage, significant expression levels or production of the 
relevant complex by either co-expression or by reconstitution) are shown with a green 
background. Similarly, „mediocre‟ results in the TAP validation (indicating that either 
heterogenous or partial complexes were purified) are shown with a yellow background. 
Negative results, indicating either a poor gel quality, low bioinformatics rank, failed TAP 
validation experiment, failed expression or failed complex production, are shown in red.  
Expression results for the complexes not deemed to be suitable for structural analysis are 
shown as gray text. 
‡
Reconstitution of the Dom34:Hbs1 complex is described previously 
(Graille et al., 2008). 
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Stage 
Complex 
Selection Validation 
Single subunit 
expression 
Complex production 
Gel 
Quality 
Rank 
TAP 
Results 
Subunit 
1 
Subunit  
2 
Re-
constitut
ion
¥
 
Separate 
plasmid co-
expression  
Operon co-
expression 
Bioinformatics 
Analysis 
        
Ste11,  
Ste50 
Good 1 
Heterogene
ous 
+ - - ND ND 
Atg17,  
Atg20,  
Atg29 
Good 27 
Partial  
(Atg29 
missing) 
+ - ND - - 
Vps27,  
Hse1 
Excellent 1 Excellent + + + + ND 
Psy2,  
Psy4,  
Pph3 
Excellent 4 
Partial  
(Pph3 
missing) 
+ - ND - ND 
Nup82, 
Nup159,  
Nsp1 
Good 4 Excellent ND ND ND ND ND 
Ede1,  
Syp1 
Good 22 Excellent ND ND ND ND ND 
Dop1,  
Mon2 
Excellent 25 
Aggregate
d 
ND ND ND ND ND 
Gel  
Analysis 
        
Gcd14,  
Gcd10 
Excellent 12 Excellent + + + + + 
Ptc2,  
Paa1 
Excellent 8 
Paa1 
promiscuo
us 
+ + + ND ND 
Met12,  
Met13 
Excellent 22 Excellent + + ND + ND 
Dug3,  
Dug2 
Excellent 9 Excellent + + ND + ND 
Ssl2,  
Yor352w 
Excellent 27 Excellent + + ND + + 
Spt6,  
Spn1 
Excellent 40 
Partial  
(Spn1 
missing) 
ND ND ND ND ND 
Literature 
Analysis 
        
Rad17,  
Mec3,  
Dcd1 
Failed 261 Failed ND ND ND ND ND 
Orc1-6 
Good 29 
Heterogene
ous 
ND ND ND ND ND 
Rbg2,  
Gir2 
Good 5 Excellent + + ND + + 
Dom34,  
Hbs1‡ 
No 
Interaction 
364 
No 
Interaction 
+ + + ND ND 
Rps28B,  
Edc3 
No 
Interaction 
364 
Edc3 
promiscuo
us 
ND ND ND + + 
Sis2,  
Ykl088w,  
Vhs3 
Partial 
Interaction 
323 
Weak 
expression 
ND ND ND ND ND 
Mtw1, 
Dsn1, 
Nnf1,  
Nsl1 
Partial 
Interaction 
11 
Weak 
expression 
ND ND ND ND ND 
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Methods 
Validation 
TAP purification 
TAP tagged strains of Saccharomyces cerevisiae were grown in 4 l of YPD 
medium (1% yeast extract, 1% bacto-peptone, 2% glucose) to an optical density 
(O.D.) of approximately 2. Yeast pellets were resuspended in 40 ml of lysis buffer (1 
mM DTT, 40 mM Hepes pH 8, 250 mM NaCl) and frozen in liquid nitrogen. Cells 
were broken in a laboratory blender cooled with dry ice. Extracts were defrosted with 
protease inhibitors and spun in 35Ti rotor (Beckman) in a Beckman ultracentrifuge at 
20,000 rpm for 20 minutes at 4°C. Supernatant was spun again at 32,000 rpm for 90 
minutes at 4°C. Resulting extracts were dialyzed in buffer D (1 mM DTT, 40 mM 
Hepes pH 8, 150 mM NaCl, 1 mM PMSF) and frozen in liquid nitrogen. Extracts 
were then defrosted and incubated with 200μl of IgG Sepharose 6 Fast Flow resin 
(GE Healthcare) in the presence of 0.1% rTX-100 for 1.5 hours at 4
o
C. The beads 
were washed twice with 10 ml IPP150 (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% 
rTX100) and twice with 10 ml TEV cleavage buffer (10 mM Tris-HCl pH 8.0, 150 
mM NaCl, 0.5mM EDTA, 1 mM DTT). TEV cleavage was performed for 2 hours 
using 20 μg of TEV protease in 300 μl of cleavage buffer at room temperature.  
Eluates were agitated with 300 μl of calmodulin beads suspension (Stratagene) for 
0.5 hours at 4
o
C. The beads were washed four times with 500 µl of calmodulin wash 
buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 10 mM β-mercaptoethanol, 1mM 
CaCl2) and the protein was eluted with 0.6 ml calmodulin elution buffer (10 mM Tris-
HCl pH 8.0, 500 mM NaCl, 10 mM β-mercaptoethanol, 0.1% rTX100, 4mM 
EDTA). As a control, denatured elution fractions from both IgG and calmodulin 
beads were prepared with 250µl of 1% SDS at 60
o
C. 
Protein precipitation and analysis by mass spectrometry 
Proteins were precipitated using pyrogallol red(Aguilar et al., 1999). When 
salinity of buffer was higher then 200 mM of NaCl the samples were first adjusted to 
this concentration by dilution. Proteins were separated by electrophoresis performed 
on NuPAGE 4-12% gradient gels using MES buffer gel system (Invitrogen) and 
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stained with SimplyBlue SafeStain (Invitrogen). Mass spectrometry was performed 
both with IgG eluates in solution and from bands cut from gels. Samples were then 
processed by standard procedures with trypsin digestion and cysteine alkylation. The 
obtained peptide mixtures were separated on a nano-HPLC system and the column 
outlet was coupled to the ion source of an LTQ FTICR spectrometer. 
Western blot analyses 
After dialysis, extracts and flow-throughs after IgG Sepharose 
chromatography were separated by 10% SDS-PAGE and electro-blotted onto the 
Protran nitrocellulose membrane (Bioscience) using a Trans-Blot® system (Bio-Rad). 
The filters were blocked for 1 h in 5% milk powder in PBS containing 0.1% Tween-
20 and then the mouse monoclonal anti-rabbit immunoglobulin–peroxidase conjugate 
(Sigma) diluted 3,000-fold was added.  After one hour, the blots were washed three 
times in PBS with 0.1% Tween-20. Finally, horseradish peroxidase conjugates were 
visualized by enhanced chemi-luminescence system (ECL, GE Healthcare). 
Mass determination of the complexes  
In order to estimate the size of the purified complex the extract from TAP-
tagged strains was separated according to size, by size exclusion chromatography on a 
Superdex 200 10/300 column (GE Healthcare) using an Akta Purifier FPLC. Two 
different salt concentrations (150 mM and 500 mM NaCl) were used for elution and 
fractions were collected into a 96 well plate. 60 μl of every fraction were spotted on 
a nitrocellulose membrane. TAP tagged subunits were detected by Dot-Blot as 
described for western blot analyses. The intensities of the spots were calculated with 
ImageQuant (GE Healthcare) and exported into chromatograms.  The column was 
calibrated using protein markers; thyroglobulin (670 kDa), ferritin (440 kDa), catalase 
(232 kDa), aldolase (154 kDa), albumin (67 kDa), ovalbumin (43 kDa) and 
chymotrypsin (25 kDa).  
Electron Microscopy and Image Processing 
The purified, over-expressed Gcd10/Gcd14 complex was fixed on a glycerol 
gradient with glutaraldehyde according to the GraFix protocol(Kästner et al., 2008). 
Fractions of the gradient were further analyzed by dot-blot analysis using an antibody 
against the 6-histidine tag. The dot blot identified a single peak with a maximum at 
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fraction 14. Samples from the peak fractions were prepared for subsequent electron 
microscopy by sandwich negative stain using uranyl acetate as previously 
described(Ulbrich et al., 2009). Samples were imaged at room temperature in a 
Philips CM120 Biotwin electron microscope at 100 kV. Data was recorded on a 
4kx4k Tietz-CCD camera at a nominal pixel size of 4.27 Å per pixel under low dose 
conditions. For further processing 10819 particle images were selected from 29 
micrographs. Three-dimensional models were calculated using sinogram correlation 
and weighted back projection with IMAGIC 5(van Heel et al., 1996). The process of 
determining initial orientations followed by calculation of a three-dimensional map 
was repeated several times using different class averages for starting the sinogram 
correlation.  
Projections of the resulting three-dimensional models were compared with the 
initial class averages. The model that generated projections that matched most of the 
initial class averages, was selected for further refinement by an iterative process of 
projection matching followed by calculating a new 3D-map with Spider(Frank et al., 
1996). After five rounds of refinement the map was stable and showed an 
approximately fourfold-symmetric core with extensions at opposite sides, giving the 
whole map a 2-fold symmetric appearance. Therefore, the map was refined for 
another five rounds imposing C2-symmetry. The resolution of the final map was 
determined by Fourier-Shell-Correlation and was 23 Å (Correlation=0.5). 
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Supplemental Table 1: Non-redundant and manually curated set of 39 distinct yeast 
complexes of known 3D structure.  
Dotted horizontal lines indicate the thresholds corresponding to the complexes in the top 10 and top 50, 
after weight optimizations. Columns two and three show the accession codes of the corresponding PDB 
entries and the ORF IDs of the different yeast proteins in the given complex, respectively. Column 4 
contains the feasibility score of the complex when ranking the 39 yeast complexes of known 3D 
structure together with the 491 complexes defined by Gavin et al., 2006, and column 5 depicts the 
corresponding rank.  
 
 
 
Supplemental Text & Figures
Complex description PDB entries Yeast ORF IDs 
Feasibility 
score 
Rank 
Crystal structure of the yeast kinetochore 
Spc24/Spc25 globular domain 
2FTX 2FV4 YER018C YMR117C 92 2 
Elongation factor complex EEF1A:EEF1BA 1f60 1G7C 1IJE 1IJF YAL003W YBR118W 91.74 3 
RabGDP-dissociation inhibitor in complex with 
prenylated YPT1 GTPase 
1UKV 2BCG YER136W YFL038C 91.55 5 
Mediator MED7/MED21 subcomplex 1YKE YDR308C YOL135C 91.48 6 
Sec23/24 heterodimer 1M2V YIL109C YPR181C 90.76 7 
20S proteasome 1G0U 1G65 1JD2 
1RYP 2F16 2FNY 
YBL041W YER012W YER094C 
YFR050C YGL011C YGR135W 
YGR253C YJL001W YML092C 
YMR314W YOL038W YOR157C 
YOR362C YPR103W 
89.07 12 
Ribonucleotide reductase Y2Y4 heterodimer 1JK0 YGR180C YJL026W 87.22 16 
Structure of a Vps23-C:Vps28-N subcomplex 2F6M YCL008C YPL065W 84.49 25 
Mitochondrial processing peptidase 1HR6 1HR7 1HR8 
1HR9 
YHR024C YLR163C 83.65 29 
Carboxypeptidase Y inhibitor complexed with the 
cognate proteinase 
1WPX YLR178C YMR297W 83.2 31 
AHA1/HSP90 complex 1USU 1USV YDR214W YPL240C 82.23 33 
Eukaryotic clamp loader (RFC) bound to the DNA 
sliding clamp (PCNA) 
1SXJ YBR087W YBR088C YJR068W 
YNL290W YOL094C YOR217W 
81.28 36 
Mms2/Ubc13 ubiquitin conjugating enzyme 
complex 
1JAT YDR092W YGL087C 81.13 37 
MLC1P bound to IQ2 of MYO2P 1M45 1N2D YGL106W YOR326W 81 38 
Heterodimer between H48F-ySOD1 and yCCS 1JK9 YJR104C YMR038C 79.97 42 
TFIIA/TBP/DNA complex 1NH2 1RM1 1YTF YER148W YOR194C 79.35 46 
A conjugating enzyme/ubiquitin thiolester 
complex 
1FXT YDR177W YLR167W 79.1 47 
Translation initiation factor eIF4E in complex with 
m7GDP and eIF4GI 
1RF8 YGR162W YOL139C 78.9 48 
ESCRT-II endosomal trafficking complex 1U5T 1W7P YLR417W YPL002C YJR102C 78.89 49 
Nucleosome core particle 1ID3 YBL002W YBR009C YBR010W 
YDR225W 
78.46 50 
SRP receptor beta-subunit in complex with the 
SRX domain from the alpha-subunit 
1NRJ YDR292C YKL154W 78.12 52 
Brf1/TBP/DNA ternary complex 1NGM YER148W YGR246C 78.04 54 
Sec23/Sar1 complex 1M2O YPL218W YPR181C 77.34 61 
Dsk2p UBA/ubiquitin complex 1WR1 YIL148W YMR276W 76.77 63 
A peptide:N-glycanase-Rad23 complex 1X3W 1X3Z YEL037C YPL096W 74.66 75 
 RNA polymerase II 1NT9 1I50 1I6H 
1NIK 1R5U 1R9S 
1R9T 1SFO 1TWA 
1TWC 1TWF 1TWG 
1TWH 1I3Q 1K83 
1WCM 1Y1W 1Y77 
2B63 
YBR154C YDL140C YDR404C 
YGL070C YHR143W-A YIL021W 
YJL140W YOL005C YOR151C 
YOR210W YOR224C YPR187W 
72.96 88 
Exportin CSE1P in complex with its cargo 
(KAP60P) and RanGTP 
1WA5 YGL238W YLR293C YNL189W 72.24 91 
RNA polymerase II/TFIIS complex 1PQV 1Y1V 1Y1Y YBR154C YDL140C YDR404C 
YGL043W YGL070C YHR143WA 
YIL021W YJL140W YOL005C 
YOR151C YOR210W YOR224C 
YPR187W 
71.21 94 
MATa2/MCM1/DNA ternary transcription 
complex 
1MNM YCL067C YMR043W 69.62 103 
CUE/ubiquitin complex 1OTR YIL148W YKL090W 68.32 119 
Cytochrome BC1 complex 1EZV 1KB9 1P84 Q0105 YBL045C YDR529C 
YEL024W YFR033C YGR183C 
YJL166W YOR065W YPR191W 
64.61 151 
MATa1/MATalpha2-3A heterodimer bound to 
DNA 
1AKH 1LE8 1YRN YCL067C YCR097W 64.19 157 
Cytochrome BC1 complex with bound substrate 
cytochrome C 
1KYO Q0105 YBL045C YDR529C 
YEL024W YFR033C YGR183C 
YJL166W YJR048W YOR065W 
YPR191W 
64.17 158 
Electron transfer Complex between cytochrome C 
and cytochrome C peroxidase 
1S6V 1U74 2B0Z 
2B10 2B11 2B12 
2BCN 
YJR048W YKR066C 63.26 167 
C-terminal ULP1 protease domain in complex 
with SMT3 
1EUV YDR510W YPL020C 56.86 218 
YPD1/SLN1 response regulator domain complex 1OXB YDL235C YIL147C 56.71 222 
Solution Structure of Ede1 UBA-ubiquitin 
complex 
2G3Q YLR167W YBL047C 56.35 225 
Lif1p/Lig4p complex 1Z56 YGL090W YOR005C 53.77 244 
Orc1p/Sir1p complex 1ZBX 1ZHI YKR101W YML065W 52.94 253 
 Supplemental Table 2: Final weights and effects of each parameter on the final selection. *; 
Proteins with trans-membrane helices were excluded from the analysis. 
 
Partial scoring function Default weight Contribution to the final score 
Average socio-affinity index 1 30.3 % 
Maximum individual protein weight 0.3 9.1 % 
Total sequence length 0.1 3.0 % 
Average number of problematic residues 0* 0 % 
Co-localization ratio 0 0 % 
Yeast two-hybrid ratio 1 30.3 % 
Complete orthologs ratio 0.1 3.0 % 
Average orthologs ratio 0.1 3.0 % 
Self-consistency 0.4 12.1 % 
 Supplemental Table 3: Results of bioinformatics triage of Gavin et al complexes.  
Complex ID Subunits Rank Score 
1 Ste11, Ste50 1 100 
2 Atg17, Atg29, Atg11 27 85.96 
3 Vps27, Hse1 1 100 
4 Psy2, Psy4, Pph3 4 99.17 
5 Nup82, Nup159, Nsp1 4 99.17 
6 Ede1, Syp1 22 87.14 
7 Dop1, Mon2 25 86.43 
 
Supplemental Table 4A: List of stoichiometric dimeric complexes identified by visual 
inspection of gels. 
No. Subunits  Gels (with hyperlinks) 
1.  Gsy1 Gsy2 SC-PG-245-SC2550(1)-5 
2.  Trr1 Trr2 
SC-PG-286-SC3097(1)-9 
SC-PG-291-SC3169(1)-4 
3.  Gdc14 Gdc10 SC-PG-260-SC2835(1)-4 
4.  Bur2 Svg1 
SC-PG-226-SC2187(1)-6 
SC-PG-257-SC2387(1)-1 
5.  Ptc2 Paa1 
SC-PG-202-SC1898(1)-6 
SC-PG-365-SC2732(3)-3 
6.  Met12 Met13 
SC-PG-264-SC3020(1)-9 
SC-PG-277-SC2455(1)-4 
SC-PG-264-SC3020(1)-9 
7.  Snx41 Snx4 
SC-PG-459-SC3504(4)-7 
SC-PG-359-SC3504(2)-2 
SC-PG-336-SC3724(1)-3 
SC-PG-326-SC3504(1)-5 
8.  Trm7 
Ymr25
9c 
SC-PG-447-SC3979(1)-9 
9.  Fbf26 
Ylr345
w 
SC-PG-283-SC2908(1)-1 
SC-PG-389-SC0279(4)-4 
10.  Ubp2 Rup1 
SC-PG-366-SC4106(1)-2 
SC-PG-422-SC4751(1)-5 
11.  Skp1 
Ymr25
8c 
SC-PG-423-SC4814(1)-3 
12.  Ydr221 Rot2 SC-PG-314-SC3454(1)-4 
13.  Qcr1 Cor1 SC-PG-330-SC2395(3)-2 
14.  Pep4 Rtn1 
SC-PG-374-SC3088(2)-8 
SC-PG-321-SC3088(1)-7 
15.  Ram2 Cdc43 SC-PG-315-SC3602(1)-9 
16.  Trm8 Trm82 SC-PG-313-SC3442(1)-5 
17.  
Ynl119
w 
Ybr281
c 
SC-PG-413-SC5018(1)-3 
18.  
Yml11
9w 
Yll032c SC-PG-413-SC5021(1)-5 
19.  Ssl2 
Yor352
w 
SC-PG-414-SC5032(1)-2 
20.  Trm12 Trm112 
SC-PG-182-SC1472(2)-5 
SC-PG-112-SC1438(1)-3 
21.  Pfk1 Pfk2 SC-PG-119-SC0365(1)-3 
22.  Toa1 Toa2 SC-PG-122-SC1519(1)-8 
23.  Sly1 
Sec17 
or Ykt6 
SC-PG-126-SC0871(1)-6 
24.  Isw1 Ioc3 
SC-PG-206-SC1982(1)-9 
SC-PG-133-SC0692(1)-4 
25.  Apm3 Apl6 
SC-PG-095-SC1063(1)-5 
SC-PG-133-SC0725(1)-6 
26.  Bmh1 Bmh2 SC-PG-137-SC1091(1)-3 
27.  Wbp1 Swp1 
SC-PG-188-SC1788(1)-7 
SC-PG-148-SC0897(1)-6 
28.  Sbf2 Sec23 SC-PG-295-SC2585(1)-9 
29.  Sec24 Sec23 
SC-PG-186-SC1621(1)-5 
SC-PG-155-SC1144(1)-5 
30.  Rat1 Rai1 SC-PG-164-SC1486(1)-4 
31.  Spt16 Pob3 
SC-PG-062-SC1012(1)-6 
SC-PG-171-SC1329(1)-6 
32.  Kgd2 Kgd1 
SC-PG-094-SC0863(1)-1 
SC-PG-025-SC0264(1)-5 
33.  Rad53 Asf1 
SC-PG-261-SC2359(2)-2 
SC-PG-090-SC1168(1)-5 
34.  Ser33 Ser3 SC-PG-030-SC0214(2)-2 
35.  Uba3 Ula1 
SC-PG-034-SC0411(1)-4 
SC-PG-034-SC0410(2)-3 
36.  Ceg1 Cet1 SC-PG-250-SC2369(1)-2 
37.  
Ybl046
w 
Psy2 
SC-PG-106-SC1412(1)-2 
SC-PG-043-SC0457(1)-7 
38.  Bdf1 Bdf2 SC-PG-049-SC0788(1)-10 
39.  Yku70 Yku80 
SC-PG-231-SC2234(1)-8 
SC-PG-055-SC1097(1)-3 
40.  Spt6 Iws1 SC-PG-077-SC1036(2)-6 
41.  Cap1 Cap2 SC-PG-078-SC1132(2)-1 
No. Subunits  Gels (with hyperlinks) 
42.  Rnr2 Rnr4 
SC-PG-213-SC2035(1)-5 
SC-PG-090-SC1153(1)-3 
43.  Srp101 Srp102 SC-PG-131-SC0199(2)-4 
44.  Gyl1 Gyp5 
SC-PG-175-SC1593(1)-5 
SC-PG-235-SC2246(1)-7 
45.  Tfa1 Tfa2 SC-PG-305-SC3228(1)-7 
46.  Nkp1 Nkp2 SC-PG-301-SC1937(1)-5 
47.  Dcs1 Dcs2 SC-PG-278-SC2903(1)-9 
48.  Nma1 Nma2 SC-PG-274-SC2907(1)-7 
49.  Nrd1 Nab3 
SC-PG-249-SC2362(1)-6 
SC-PG-232-SC2290(1)-6 
50.  Rvs161 Rvs167 
SC-PG-248-SC1857(1)-1 
SC-PG-341-SC3099(1)-8 
51.  Clc1 Chc1 
SC-PG-211-SC2033(1)-6 
SC-PG-062-SC1011(1)-5 
52.  Itc1 Isw2 
SC-PG-123-SC1540(1)-3 
SC-PG-210-SC2001(1)-1 
53.  Pan2 Pan3 SC-PG-058-SC0987(1)-8 
Supplemental Table 4B: List of stoichiometric trimeric complexes identified by visual 
inspection of gels. 
No. Subunits Gels (with hyperlinks) 
54.  Arc1 Mes1 Gus1 
SC-PG-213-SC2048(1)-9 
SC-PG-210-SC2011(1)-8 
55.  
Tef1/T
ef2 
Cam1 Efb1 SC-PG-249-SC2348(1)-2 
56.  Lat1 Pda1 Pdb1 
SC-PG-172-SC1752(1)-5 
SC-PG-152-SC1390(1)-3 
57.  Nup82 Nsp1 Nup159 
SC-PG-151-SC1632(2)-5 
SC-PG-121-SC1633(1)-6 
58.  Hat1 Hat2 Hif1 SC-PG-033-SC0392(1)-1 
59.  Tps1 Tps1 
Tps3 or 
Tsl1 
SC-PG-031-SC0596(1)-6 
SC-PG-202-SC1899(1)-7 
SC-PG-230-SC2218(1)-5 
SC-PG-236-SC2254(1)-3 
 
 
Supplemental Table 4C: List of stoichiometric tetrameric complexes identified by visual 
inspection of gels. 
No. Subunits Gels (with hyperlinks) 
60. 0 Cka1 Cka2 Ckb1 Ckb2 
SC-PG-198-SC1820(1)-6 
SC-PG-114-SC1485(1)-3 
61.  
Stp2
2 
Ygr206w Srn2 Vps28 SC-PG-310-SC3363(1)-8 
62.  
S
Spc2
5 
Spc24 Nuf2 Tid3 SC-PG-369-SC4402(1)-6 
63.  Rlr1 Hpr1 Thp1 Mft1 SC-PG-162-SC1405(1)-4 
64.  
Sec6
2 
Sec66 Sec63 Sec72 SC-PG-306-SC2332(1)-6 
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Supplemental Figure Legends  
Supplemental Figure 1: Experimental validation of complexes 
Experimental validation of the complexes was based on tandem affinity 
purification. To test the existence of a potential complex in vivo, we used several 
yeast strains; each with expression of the TAP tagged protein from the complex. 
Tandem affinity purification of TAP tagged proteins was prepared in native 
conditions, which allows for co-purification of all other proteins forming a complex.  
In the top left panel of each page, the results from independent purifications of all 
proteins forming a potential assemble are presented. Proteins from 5 fractions 
obtained during TAP purification (1; IgG SDS eluate, 2; Calmodulin SDS eluate, 3; 
IgG eluate, 4; Calmodulin flow, 5; Calmodulin eluate) were separated on 4-12 % 
gradient SDS-PAGE gels. Proteins were visualized with Coomassie staining. Protein 
bounds marked with numbers and proteins from the IgG eluate were analyzed with 
the use of mass spectrometry. Identified proteins were listed below, together with the 
obtained score. To conclusively validate a complex, all its components should be 
visible in gel, in a calmodulin eluate fraction, or at least identified by mass 
spectrometry in an IgG eluate. To check the expression of TAP tagged proteins, their 
stability and strength of binding to IgG, western blots were prepared. Total proteins 
from yeast extracts (1) and from the IgG flow-through (2) were separated on 10% 
SDS-PAGE gels and transferred to a nitrocellulose membrane. Western blots were 
prepared with the use of PAP antibodies. The results are presented in the top right 
panel of each page. In order to estimate the size of the complexes, yeast extracts were 
separated with the use of size exclusion chromatography on a Superdex 200 column 
in low (150mM) and high (500mM) concentration of NaCl. 30 fractions from each 
chromatography were collected and spotted on a nitrocellulose membrane. PAP 
antibodies were used to detect fractions containing the TAP tagged protein. Intensity 
of spots was calculated and visualized as curves in the bottom panel of each page. The 
column was calibrated with the use of protein markers. Each experiment corresponds 
to validation of the complexes indicated at the top of each panel.  
Supplemental Figure 2: Expression & Solubility Trials 
15% SDS-PAGE of total extract (T) and clarified (S) cell lysates. Each protein 
was expressed in BL21 Gold (DE3) (Stratagene) or Rosetta2 (DE3) (Novagen) cells 
at 15°C (indicated by 15), 28°C (28), and 37°C (37). 10 µL of total and soluble 
fraction were performed by SDS-PAGE and Coomassie blue stain was used for 
visualizing the gel, as was for Supplemental Figures 2-8. Molecular weight markers 
and their sizes are indicated at right. Each band adjudged to be of approximate 
molecular weight concordant with the proteins of interest is indicated by a red 
asterisk. 
Supplemental Figure 3: Paa1-Ptc2 Purification & Complex 
Reconstitution 
Panel A: SDS-PAGE of fractions from Ni
2+
-NTA chromatography: "FT", flow 
through, "0", "50", "100", "200" correspond to washes with standard buffer, including 
imidazole added to the concentration indicated (in mM). Each protein (Paa1, above 
and Ptc2, below, labelled at left with an arrow to denote the protein of interest) were 
expressed at both 15°C and 37°C (indicated with bars above the gel). The proteins 
were soluble at both of these temperatures. Molecular weight markers and their sizes 
are indicated to the right of all gels. Panel B: Complex Reconstitution between Paa1 
and Ptc2 using a Superdex 75 10/30 (GE Healthcare) gel filtration chromatography. 
Control fractionations of either Paa1, injected alone (grey dotted line) or Ptc2 alone 
(grey solid line) eluted later than the more excluded Ptc2-Paa1 complex (solid black 
line). SDS-PAGE of selected fractions from a 96-well fraction collector are shown 
below the chromatogram (280 nm absorbance). The lanes compare the injected 
sample (INJ), as well as the peak fractions (D6-E7), demonstrating the presence of 
both proteins in the shifted peak.  
Supplemental Figure 4: Vps27-Hse1 Purification & Complex 
Reconstitution 
Panel A: SDS-PAGE of fractions from Ni
2+
-NTA chromatography: "FT", flow 
through, "0", "30", "100", "400" again correspond to the imidazole concentration in 
mM. Each protein (Vps27, above and Hse1, below, again labelled to the left with an 
arrow) were expressed at 37°C (indicated as the previous figure). Both proteins were 
soluble at both of these temperatures. Molecular weight markers and their sizes are 
indicated. Panel B: Complex Reconstitution between Vps27 and Hse1 using a 
Superdex 200 10/30 (GE Healthcare) gel filtration chromatography. Control 
fractionations of either Hse1, injected alone (grey dotted line) or Vps27 alone (grey 
solid line) eluted later than the more excluded Vps27-Hse1 complex (solid black line). 
SDS-PAGE of selected fractions from a 96-well fraction collector are shown below 
the chromatogram (280 nm absorbance). The samples compare the injected sample 
(INJ), as well as the peak fractions (D6-E7), demonstrating the presence of both 
proteins in the shifted peak. 
Supplemental Figure 5: Gcd10-Gcd14 Purification & Complex 
Reconstitution 
Panel A: SDS-PAGE of fractions from Ni
2+
-NTA chromatography: "FT", flow 
through, "0", "50", "100", "200" correspond to washes with standard buffer, with 
imidazole added to the concentration indicated (in mM). Each protein (Gcd10, above 
and Gcd14, below, (labelled as in Supp. Fig. 3), and both were soluble at both of these 
temperatures. Molecular weight markers and their sizes are indicated at right. Panel 
B: It was not possible to purify Gcd10 or Gcd14 in a non-aggregated form singly, so 
cells expressing each of the proteins alone (Gcd10 and Gcd14, as used in panel A), 
were combined and sonicated together after being resuspended in a buffer containing 
1M NaCl and purified using Ni
2+
-NTA chromatography as in panel A. Fractions 
containing Gcd10 and Gcd14 were then loaded onto a Superdex S200 10/30 column, 
yielding a single, symmetrical peak containing both proteins. Estimation of the 
molecular weight of the complex by comparison with the elution volumes of 
molecular weight standards ferritin (440 kDa), beta-amylase (200 kDa) and aldolase 
(158 kDa)  (arrowed) indicates that the complex is of approximately 300 kDa. 
Supplemental Figure 6: Ste11-Ste50 Purification & Complex 
Reconstitution 
Panel A: SDS-PAGE of fractions from Ni
2+
-NTA chromatography: "FT", flow 
through, "0", "50", "100", "200" correspond to washes of with standard buffer, with 
imidazole added to the concentration indicated (in mM). Each protein (Ste50, above 
and Ste11, below, labelled at left with an arrow to denote the protein of interest) were 
expressed at both 15°C and 37°C (indicated with bars above the gel). Ste11 was found 
to be insoluble at both of these temperatures, however. Molecular weight markers and 
their sizes are indicated to the right. Stay tuned for updates on Ste11 expression. Panel 
B: Sonication of cells expressing Ste11 and Ste50 (as per the Gcd10:Gcd14 complex) 
did not yield soluble Ste11. The upper band after gel filtration (arrowed), despite 
having a molecular weight approximately similar to Ste11 was identified as a 
contaminant from E. coli. 
Supplemental Figure 7: Effects of expression using synthetic genes 
using codon optimization relative to naturally occurring genes 
SDS-PAGE of fractions from Ni
2+
-NTA chromatography purifications of co-
expressed Gcd10/Gcd14 (Panel A) and Ssl2/Yor352w (Panel B) as synthetic, codon-
optimized genes (above), compared to the naturally-occurring yeast DNA sequences 
(below). Fractions are labelled as follows: “T”, total cells prior to sonication; “P”, 
pellet post-sonication, “S”; supernatant post-sonication, “FT”; flow through, “E1” & 
“E2” are specific elutions with buffer including 300 mM imidazole. Note the 
increased yield when using codon-optimized genes in both cases. 
 
Supplemental Experimental Procedures  
Algorithms for the selection of complexes using bioinformatics 
We have already described a selection system to rank protein assemblies based 
on various parameters (Pache and Aloy, 2008), but recapitulate it here. The algorithm 
is based on the notion that promising target complexes should be small, compact and 
homogeneous in order to yield successful expression, purification and structure 
determination. To rank the complexes, biophysical, biochemical and large-scale 
proteomics data are incorporated in the form of partial scoring functions that we then 
normalized and combined into a final feasibility score for each complex. 
Briefly, the first individual score refers to the average socio-affinity index of 
the complex (Gavin et al., 2006), which quantifies the tendency of two proteins to 
interact with each other when tagged and to co-purify when yet other proteins are 
tagged. The higher the average socio-affinity of a complex, the more of its proteins 
are predicted be in direct contact, which could be used as an indication for the 
compactness of the complex. We also consider the molecular weight and the total 
sequence length of the complex components, since larger proteins are usually more 
difficult to express. We penalize the presence of low complexity regions, internal 
repeats, coiled coils and intrinsically disordered stretches, since they often result in 
insoluble proteins that aggregate when over-expressed (Dale et al., 2003).  
Information regarding sub-cellular localization (Huh et al., 2003) and 
abundance (Ghaemmaghami et al., 2003) of individual proteins is also considered, 
since complex components are expected to be consistent in these terms. Another 
criterion employed is the level of conservation of a complex across evolution, which 
we addressed by considering orthologous protein relationships in 83 eukaryotic 
species (von Mering et al., 2007). We also used binary interactions extracted from 
yeast two-hybrid screens in combination with the number of isoforms described for 
each complex to estimate its self-consistency. This is to capture the independence and 
homogeneity of each complex with respect to the others. For instance, if a complex 
contains many binary interactions between its own subunits and few with proteins 
from other complexes, this decreases the probability of missing components in the 
definition of the complex. Additionally, the fewer isoforms the more invariant the 
protein cluster is. Finally, we used cumulative probabilities to normalize each score to 
the range [0,1], and calculated a global feasibility score as the weighted average of all 
normalized partial scores. The final score 

S(c) assigned to each protein complex 

c  is 
calculated by taking the weighted average of all normalized partial scores 

si(c) , 
ignoring those which are not applicable for the respective protein complex (e.g. the 
'Average abundance ratio' when the abundance of none of the proteins in the 
respective complex could be determined), and multiplying by 100. 
Using a weighted average to combine all partial scores makes it possible to 
give each partial score a particular weight 

wi, which allows us to evaluate its 
importance and to control its impact on the final score: 
 
 
S(c)1 0 0
wiP
(si(c)x)
i

wi
i

,wi[0,1]
 
 
 
P

(si(c) x) denotes the cumulative probability that the partial score 

si(c)  of 
the protein complex 

c  is equal to 

x , used for normalization to take into account the 
distribution of the respective partial score and calculated by taking the sum of all 
probabilities 

P(si(c)  y) over all values 

yx  or 

yx , depending on whether 
higher or lower values are better for the respective ranking criterion:  
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Cloning into T7 promoter-based expression systems 
Cloning strategy used for single-subunit expression 
For the expression and production of single proteins, a cloning strategy to 
generate C-terminally 6His-tagged proteins was employed. In order to minimize the 
possibility that errors could be introduced into the primers, to test for the presence of 
restriction sites in the gene, and to find optimal melting temperatures for primer pairs, 
a web interface-based script was written. The web interface is part of a basic 
laboratory information management system (LIMS), which additionally allows the 
storage of the primers in a structured query language (SQL) database. The software is 
open source, and freely available: http://plasmidb.sourceforge.net. 
PCR reactions were performed with oligonucleotides which encoded either a 
5´ Nco I or Nde I restriction site (the choice of restriction site was determined by the 
absence of this restriction site in the gene of interest), and a 3´ primer which contains 
a Not I site, followed by a sequence encoding a 6His tag and a stop codon. The 
oligonucleotides used in this study are listed in Supplemental Table 1. PCR using 
these primers and Saccharomyces cerevisiae S288C genomic DNA as template 
yielded DNA fragments of the expected size for all of the desired genes, except for 
Ste11, which we were unable to produce. The resulting PCR products that encoded a 
5´ Nde I site were cloned into the vector pET9 (Novagen), and those containing Nco I 
sites were cloned into pET28 (Novagen), using standard procedures. Since it was not 
possible to obtain a PCR product of Ste11, despite numerous attempts with different 
primers and melting temperatures, the gene encoding Ste11 was ordered as a synthetic 
gene. 
Cloning strategy used for multi-plasmid co-expression  
The vector DNA pET-NKIb 3C/LIC (10µg) was digested with Kpn I (2-3h at 
37°C; NEB) and purified with a QIAquick spin column (Qiagen) according to the 
manufacturer's protocol. The linearised vector was treated with T4 DNA Polymerase 
in the presence of 25 mM dTTP to generate single-strand overhangs. The reaction was 
incubated at room temperature for 30 min and inactivated by incubating at 75°C for 
20 min. Target genes were amplified by PCR using the Pfu Turbo polymerase 
(Stratagene). For the pET-NKIb 3C/LIC the 5'-end of the primers must incorporate 
the CAGGGACCCGGT sequence upstream the forward PCR primer and the 
CGAGGAGAAGCCCGGTTA sequence upstream of the reverse primer (which 
includes a TAA stop codon). For the pET-NKIb LIC without a 6His-tag (no-tag 
constructs), the sequence GGGCCCGGCGATG must be incorporated in the 5'-end of 
the primers. A web server enabling the high throughput design of PCR primers was 
used and is freely available at http://xtal.nki.nl/ccd. The PCR products were purified 
prior to T4 treatment (QlAquick PCR purification kit by Qiagen); 0.2 pmol of purified 
PCR DNA was treated with T4 DNA Polymerase in the presence of 25 mM dATP to 
create the single-strand overhangs. The reaction was incubated at room temperature 
for 30 min and inactivated by incubation at 75°C for 20 minutes. 
Annealing of the vector and insert was achieved by mixing 1 μl pET-NKIb 
3C/LIC vector (50ng/μl) with 2 μl insert (0.02 pmol). The reactions were incubated 
at RT for 5 min, after which 1 μl of 25 mM EDTA was added. Typically, half of the 
annealing reaction (2µl) is transformed into NovaBlue competent cells (Novagen) and 
after overnight incubation at 37°C, the annealing and transformation efficiency can be 
verified. A typical transformation protocol was used (incubation on ice-20 min; heat 
shock- 30 sec at 42°C; incubation on ice 2 min; addition of 80 μl LB medium to 
each sample and incubation at 37°C for 1 hour) and transformants are plated on LB 
agar supplemented with kanamycin (30mg/ml for all his-tag constructs) or ampicillin 
(100mg/ml; for all no-tag constructs) and incubated at 37°C overnight. Plasmid DNA 
was extracted from single colonies using a miniprep kit (Qiagen) and restriction 
digestion was used to verify the presence of the insert of interest. 
Cloning strategy used for poly-cistronic expression 
For operon constructions, oligonucleotides were designed to amplify coding 
regions by PCR. Oligonucleotides contained restriction sites selected to be unique in 
the final plasmid, allowing the simultaneous insertion of both ORFs in the plasmid 
vector pBS3021. Oligonucleotides contained in addition a Shine-Dalgarno sequence 
upstream of the second ORF and a sequence encoding a 6His tag fused in-frame 
upstream or downstream of one of the two ORFs. PCR fragments were inserted by 
standard cloning downstream of the T7 promoter of the pBS3021 expression vector. 
DNA purifications were performed on an EPmotion robot (Eppendorf) using a 
Macherey-Nagel mini-preparation kit followed by digestion and gel electrophoresis to 
ascertain the presence of the desired inserts. Inserted fragments were entirely 
sequenced to confirm the absence of PCR-induced mutations. 
Expression testing 
Expression testing of individual subunits 
The initial objective in this part of the study was to define expression 
conditions that gave optimal yields of soluble protein for each full-length protein. 
Therefore, each expression vector under study was initially transformed into both 
Rosetta pLysS (Novagen) and Gold (Stratagene) in a 24-well block (Corning, Inc.). 
After incubation overnight in 5 ml per well of 2x Yeast Tryptone (2YT hereafter) 
medium supplemented with 30 μg/ml kanamycin at 37°C, this pre-culture was used 
to inoculate 10 ml per well of similar media as the expression culture, again using 
2YT broth supplemented with 30 μg/ml kanamycin. The volume of the inoculum 
used was adapted according to its OD600 so as to obtain a starting optical density of 
0.1 for the expression culture. This culture was incubated until the OD600 reached ~1, 
then was separated into three 1ml aliquots, one for each of the expression 
temperatures under study: 37ºC, 28ºC and 15ºC. After the addition of IPTG to a final 
concentration of 0.5 mM, the cells were incubated either for 4 hours at 37ºC, or for 
16-18 hrs for the inductions at 28ºC and 15ºC. Cells were harvested by centrifugation 
of the 24-well block at 5,300 rpm for 1 hour. 
The pellets in each well were re-suspended with lysis buffer (20 mM Tris-
HCl, pH 7.5, 200 mM NaCl, 5mM β-mercaptoethanol). The 24-well block 
containing the cell suspension was sonicated with 1 mM benzonase, 4 times for 10 
minutes, and then centrifuged at 5,300 rpm for 1 hour. The crude and clarified cell 
lysates were analyzed using SDS-PAGE (Table 1, column labeled “Single subunit 
expression” and Supplemental Fig. 1). All proteins except for Ste11 could be 
produced in a soluble form. Expression from a construct corresponding to Ste11 did 
not yield soluble protein, however. An expressed band apparent in purifications at 
approximately the expected size of Ste11 was in fact identified by mass spectrometry 
of tryptic digest of this band as polymyxin resistance protein arnA (UniProt accession 
code; P77398), a common contaminant of purifications originating from E. coli. 
Expression testing for multi-plasmid co-expression 
Small-scale protein expression and solubility screening was carried out for 
single constructs of full-length proteins, for constructs of individual or combinations 
of domains as well as for co-expressions of partners. For the transformation of single 
plasmids, plasmid DNA was transformed into E. coli Rosetta2 (DE3) T1R. Single 
colonies were used for small-scale expression trials in a 24-well 'Deepwell' block 
(Corning). Each well contained 3ml LB media supplemented with kanamycin 
30mg/ml. For the transformation of multiple plasmids to co-express complexes, 
plasmid DNA of the two partners of interest was transformed into Rosetta2 (DE3) 
T1R E. coli and plated onto LB agar plates supplemented with 30 mg/ml kanamycin 
and 100 mg/ml ampicillin. Single colonies were used for small-scale expression trials 
in a 24-well 'Deepwell' block. Each well contained 3 ml LB media supplemented with 
30mg/ml kanamycin and 100 mg/ml ampicillin. 
The 24-well block was incubated in a shaking incubator at 500 rpm until an 
OD600 of about 0.6-0.8 had been attained, at which point the temperature was reduced 
to 16°C and the cultures were induced by the addition of IPTG to a final 
concentration of 1 mM. Incubation was continued for 16-18 hrs and cells were 
harvested by centrifugation of the Deepwell block at 4,000 rpm for 15 minutes. The 
pellets in each well were resuspended with lysis buffer (40% sucrose, 50 mM Tris-
HCl pH 7.5, 200 mM NaCl, 5mM β-mercaptoethanol, 4mg/ml lysozyme (Novagen), 
DNAse and PMSF). The 24-well block containing the cell suspension was incubated 
in a temperature controlled shaking incubator at 300 rpm, for 20 minutes at 10°C and 
then centrifuged at 4,000 rpm for 15 minutes. The clarified cell lysate was then mixed 
with 25 μl pre-equilibrated MagneHis Ni-beads (Promega) and incubated at 4°C for 
30 minutes. The Magnetight HT96 stand (Novagen) was used to pull down the 
MagneHis beads. The magnetic beads were washed 3 times with 1 ml wash buffer 
(lysis buffer supplemented with 20 mM imidazole). Protein elution was performed by 
adding 30 μl elution buffer (wash buffer containing 400 mM imidazole) to each 
sample and eluted fractions were analyzed by SDS-PAGE.  
Expression testing for polycistronic co-expression 
Proteins were expressed in BL21(DE3) codon+ E. coli using auto-induction 
media(Studier, 2005). Small scale (3 ml) or large scale (100-200 ml) cultures were 
performed. After overnight incubation at 25°C, cells were harvested. For small-scale 
cultures, lysis was performed with lysozyme and benzonase. After centrifugation, the 
supernatant was incubated with Ni-NTA beads for 1h at 4°C. After washing the 
column with equilibration buffer (50 mM Tris HCl pH7.4, 20 mM imidazole, 300 
mM NaCl, 2 mM ß-mercaptoethanol, 0.2 % NP40, 10 % glycerol), proteins were 
eluted with 500 mM imidazole. For large-scale culture, pellets were washed with PBS 
and dissolved in 20 ml of equilibration buffer. Cells were lysed using a “Constant Cell 
Disruption System”. After centrifugation, the supernatant was filtered and purified by 
chromatography on Ni
2+
-NTA (Akta system, Hitrap Ni
2+
 1 ml column volume). After 
washing with equilibration buffer, elution was performed with a linear gradient from 
0 to 100% of elution buffer (50 mM Tris HCl pH 7.4, 500 mM imidazole, 300 mM 
NaCl, 2 mM ß-mercaptoethanol, 0.2% NP40, 10% glycerol). All eluates were 
analyzed by means of SDS-PAGE. 
Complex Formation Trials 
Reconstitution of complexes from individually purified partners 
We purified Paa1 and Ptc2 to approximate homogeneity using gel filtration 
and concentrated them individually to 2 mg/ml. The two proteins were combined in a 
500 μl reaction mixture (250μl of each component), and were incubated on ice at 
4°C. Gel filtration chromatography illustrated that the proteins co-elute, shifting the 
peak of Ptc2 by 1.3 ml upon addition of the Paa1 subunit (Supplemental Fig. 3). In a 
similar manner to the Paa1-Ptc2 complex, both Vps27 and Hse1 could be produced in 
a soluble form, and the proteins were produced using expression at 37°C henceforth 
(Supplemental Fig. 4, Panel A). Vps27 and Hse1 proteins were purified to 
homogeneity using a final gel filtration step. 10nM of each of the proteins were 
injected separately into an S200 analytical column. Both proteins were then combined 
and incubated for 30 minutes at 4°C and subjected to gel filtration (Supplemental Fig. 
4, Panel B).  The complex eluted at 11.03 ml, compared to the individual profiles of 
Vps27 (11.67 ml) and Hse1 (13.58 ml). Both proteins appear to be in the peak 
fractions, as judged by SDS-PAGE (Supplemental Fig. 4, lower Panel A). Gcd10 and 
Gcd14 posed severe problems when purified individually, even from refolded 
material. Despite being able to obtain both proteins in a relatively soluble form 
(Supplemental Fig. 5, Panel A), they had a tendency to aggregate as judged by their 
elution in the void volume of a Superdex S200 column. Eventually, co-sonication of 
the individually expressed proteins was attempted, which improved the situation 
considerably. However, it was only when co-sonication was performed in the 
presence of a high salt buffer (1M NaCl) that an acceptable elution profile was 
obtained, as has been previously reported (Ozanick et al., 2005) (Supplemental Fig. 5, 
Panel B). Formation of the complex between Ste11 and Ste50 was prevented by the 
lack of soluble expression of Ste11 (Supplemental Fig. 6, Panel A, lower) even when 
co-expressed with Ste50. Ste50 could be produced in a soluble form even when 
expressed alone, although what appeared to be degradation products were visible 
(Supplemental Fig. 6, panel A, upper). 
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